Crossmark

Association of Angiotensin Receptor-Neprilysin Inhibitors Use and Better Cardiorenal Outcomes in Patients With Heart Failure and Acute Kidney Disease

Published Online: 2025-04-23

Authors

Chen, Jui-Yi https://orcid.org/0000-0003-1376-7780
Pan, Heng-Chih

Wu, Vin-Cent
Funding

Funding for this research was provided by:

Chi Mei Medical Center (CMOR11303)

National Science and Technology Council (NSC 101-2314-B-002-132-MY3)
License Information

Text and Data Mining valid from 2025-04-23

Version of Record valid from 2025-04-23
More Information

Article History

Accepted: 8 April 2025

First Online: 23 April 2025

Declarations

:

: The TriNetX platform adheres to both the Health Insurance Portability & Accountability Act (HIPAA) and the General Data Protection Regulation (GDPR). Furthermore, the utilization of TriNetX for the current study received formal approval from the Institutional Review Board of Chi-Mei Medical Center (Approval No: 11210-E01). Our study was conducted in strict accordance with the ethical principles delineated in the Declaration of Helsinki.

: Not applicable.

: All authors have provided their consent for the publication of this manuscript.

: All authors have no conflict of interest.

Document is current